The Disruptors

Bruce sits down with Thomas Cahill to discuss his unique journey from the laboratory to the forefront of life sciences investing, with advanced degrees from Duke University and a foundation in chemistry.

What happens when a U.S. intelligence director and the founder of Priceline build an AI company together and start with food? The internet profoundly changed global operations, but the current generation of artificial intelligence is poised to make.

In Part 2, Thomas Cahill dives deeper into the venture creation model that has made Newpath Partners a force in biotechnology. As a founder, investor and board member across numerous groundbreaking healthcare companies, Tom explains how he aligns.

In Part 1, Lawrence Calcano shares how he left Goldman Sachs to build iCapital, overcame the early chicken-and-egg challenge, and transformed alternative investing for financial advisors. Learn the lessons, mindset, and vision behind one of finance.